Weather - NCM Forecasts Chance of Rain Across Four Days Transport - Dubai Commuters Can Now Use QR Codes for Metro, Bus and Tram Jo… Update - Abu Dhabi Announces Three-Day Road Closure on Shakhbout Bin Sul…

Send an Inquiry

Fill in the details below and our team will get back to you.

Technology 1 min read 31 views

Halcyon Secures $100M Series C Funding to Combat Ransomware Threats

Cybersecurity Innovator Expands Middle East Presence with Groundbreaking Anti-Ransomware Platform

Halcyon, the world’s only company dedicated exclusively to defeating ransomware, has announced the successful closure of its $100 million Series C funding round. Led by Evolution Equity Partners, the funding propels Halcyon to a valuation of $1 billion, underscoring its position as the premier provider of a purpose-built Anti-Ransomware Platform. The platform leverages cutting-edge AI-driven technology to eliminate the business impact of ransomware attacks.

This milestone comes as Halcyon expands its footprint into the Middle East, introducing its proprietary Anti-Ransomware Platform to address the escalating ransomware threats in the region. The expansion aligns with the company’s mission to bolster global cybersecurity defenses.

Jon Miller, CEO and Co-Founder of Halcyon, emphasized the urgency of combating ransomware: “Ransomware is unique in cybercrime because of its tangible impact on everyday people. When patients can’t get healthcare, workers can’t do their jobs, and the most vulnerable among us are directly extorted because their most personal information was exfiltrated in a ransomware attack, we are talking about attacks that are unlike any we have seen before.”

Key Highlights from the Announcement:

  • $100M Series C Funding: The round was led by Evolution Equity Partners with participation from Bain Capital Ventures, SYN Ventures, ServiceNow Ventures, and others.

  • Innovative Technology: Halcyon’s proprietary AI/ML solutions prevent ransomware attacks, enable system recovery within minutes, and stop data exfiltration threats.

  • Industry Impact: With over $1 billion paid in ransomware ransoms in 2023 and average recovery costs of $4.45 million, Halcyon’s solutions are uniquely positioned to protect businesses and individuals.

  • Unparalleled Success Rate: None of Halcyon’s customers have paid ransoms, lost data, or experienced significant downtime due to ransomware attacks.

The funding round highlights growing investor confidence in Halcyon’s mission to combat the ransomware epidemic. By providing organizations with advanced tools and data-driven insights, Halcyon is setting a new standard in cybersecurity resilience.

Halcyon raises $100M in Series C fundingled by Evolution Equity Partnersto expand its AI-driven Anti-Ransomware Platform and strengthen global cybersecurity

Related News

More on Technology

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Real Estate

Writing Dubai Rental Disputes Center Settles 2,350 Cases Worth Dh401 Million in Nine Months

Dubai’s Rental Disputes Center (RDC) resolved 2,350 rental disputes through amicable settlements during the first nine months of 2026, with the cases valued at Dh401 million. The cases, concluded between January and the end of September, took an average of six days to resolve, highlighting...

Oct 10, 2026 · 2 min
Business

Future 100 honours third cohort and opens registration for new edition

The UAE’s Future 100 initiative has recognised its third cohort of 100 companies operating in new economy sectors and announced that registration and nominations for its next edition will open in October. The recognition ceremony took place during Investopia Bridge 2026 in Abu Dhabi, in the...

Oct 10, 2026 · 3 min
Business

Three UAE companies win GCC Industrial Excellence Awards at Made in GCC 2026

HALCON, IMMENSA and Quantum Pharma — have received the GCC Industrial Excellence Award 2026 at the inaugural Made in GCC Forum and Exhibition in Bahrain, recognising their contributions to advanced manufacturing, industrial innovation and local production. The UAE, represented by the...

Oct 10, 2026 · 4 min
Healthcare

ADCAN Pharma Signs Five International Partnerships to Expand UAE Drug Manufacturing

UAE-based pharmaceutical manufacturer ADCAN Pharma has signed five licensing and local manufacturing agreements and binding term sheets with international partners to expand its product portfolio and strengthen medicine production across the UAE, Saudi Arabia and the wider Middle East. The...

Oct 9, 2026 · 2 min

Our Associates


Add Business Card Add Event Add Directory Add Forum